Vida Tajiknia

Also affiliated with CVS Health (United States)

MedicineBiochemistry, Genetics and Molecular BiologyImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Exosomal microRNAs and exosomal long non-coding RNAs in gynecologic cancers”.

Exosomal microRNAs and exosomal long non-coding RNAs in gynecologic cancers

Gynecologic Oncology(2021)10.1016/j.ygyno.2021.02.004

N/A

0DataRank · unranked

99 citations

Homa Boroumand, Samaneh Mollazadeh, Vida Tajiknia, Zahra Nourollahzadeh, Mina Rohani Borj +5 more

Therapeutic targeting of TRAIL death receptors

Biochemical Society Transactions(2023)10.1042/bst20220098

N/A

0DataRank · unranked

48 citations

Andrew George, Vida Tajiknia, Maryam Ghandali, Laura Jinxuan Wu, Yiqun Zhang +10 more

Synergistic anti-tumor activity, reduced pERK, and immuno-stimulatory cytokine profiles with 5-FU or ONC212 plus KRAS G12D inhibitor MRTX1133 in CRC and pancreatic cancer cells independent of G12D mutation

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.09.13.557593

N/A

0DataRank · unranked

1 citations

Maximilian Pinho-Schwermann, Praveen R. Srinivasan, Liz Hernandez Borrero, Leiqing Zhang, Kelsey E. Huntington +2 more

Synergistic anti-tumor activity, reduced pERK, and immuno-stimulatory cytokine profiles with 5-FU or ONC212 plus KRAS G12D inhibitor MRTX1133 in CRC and pancreatic cancer cells independent of G12D mutation

American Journal of Cancer Research(2024)10.62347/dvxl1377

N/A

0DataRank · unranked

6 citations

Vida Tajiknia